Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuki Hashimoto

Showing results (191-200 of 211) with videos related to

Pageof 22
Sort By:
In Vivo (Athens, Greece)|March 4, 2022
Retrospective Study of Cisplatin/Carboplatin, 5-Fluorouracil Plus Cetuximab (EXTREME) for Advanced-stage Salivary Gland CancerTakafumi Nakano, Ryuji Yasumatsu, Kazuki Hashimoto, et al.
Chest|June 6, 2022
Drug-Related Pneumonitis Induced by Osimertinib as First-Line Treatment for Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Real-World SettingYuki Sato, Hiromitsu Sumikawa, Ryota Shibaki, et al.
Antimicrobial Agents and Chemotherapy|October 8, 2024
Variability of macrolide-resistant profile in <i>Mycobacterium avium</i> complex pulmonary diseaseKiyoharu Fukushima, Yuki Matsumoto, Yuko Abe, et al.
International Immunology|April 24, 2026
Distinct fibrosis-associated macrophage subsets coordinate iron metabolism in pulmonary fibrosisHiroshi Nabeshima, Kiyoharu Fukushima, Yu-Chen Liu, et al.
Frontiers in Immunology|January 27, 2025
Nationwide multi-centric prospective study for the identification of biomarkers to predict the treatment responses of nivolumab through comprehensive analyses of pretreatment plasma exosome mRNAs from head and neck cancer patients (BIONEXT study)Kuniaki Sato, Satoshi Toh, Taku Murakami, et al.
American Journal of Ophthalmology|May 8, 2026
Genotype-phenotype correlations in RPGRIP1-associated retinal dystrophy in a nationwide Japanese cohortKei Mizobuchi, Taiga Inooka, Takuya Aoki, et al.
Journal of Medical Genetics|March 18, 2024
Disease-specific variant interpretation highlighted the genetic findings in 2325 Japanese patients with retinitis pigmentosa and allied diseasesKensuke Goto, Yoshito Koyanagi, Masato Akiyama, et al.
Ophthalmology|July 18, 2024
Genetic Risk Stratification of Primary Open-Angle Glaucoma in Japanese IndividualsMasato Akiyama, Gen Tamiya, Kohta Fujiwara, et al.
BMC Cancer|October 31, 2023
Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from JapanKenji Tsuchihashi, Mamoru Ito, Shuji Arita, et al.
JTO Clinical and Research Reports|December 4, 2023
Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA StudyYasunori Murata, Shigeru Tanzawa, Toshihiro Misumi, et al.
Pageof 22

Showing results (191-200 of 211) with videos related to

Sort By:
Pageof 22
In Vivo (Athens, Greece)|March 4, 2022
Retrospective Study of Cisplatin/Carboplatin, 5-Fluorouracil Plus Cetuximab (EXTREME) for Advanced-stage Salivary Gland CancerTakafumi Nakano, Ryuji Yasumatsu, Kazuki Hashimoto, et al.
Chest|June 6, 2022
Drug-Related Pneumonitis Induced by Osimertinib as First-Line Treatment for Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Real-World SettingYuki Sato, Hiromitsu Sumikawa, Ryota Shibaki, et al.
Antimicrobial Agents and Chemotherapy|October 8, 2024
Variability of macrolide-resistant profile in <i>Mycobacterium avium</i> complex pulmonary diseaseKiyoharu Fukushima, Yuki Matsumoto, Yuko Abe, et al.
International Immunology|April 24, 2026
Distinct fibrosis-associated macrophage subsets coordinate iron metabolism in pulmonary fibrosisHiroshi Nabeshima, Kiyoharu Fukushima, Yu-Chen Liu, et al.
Frontiers in Immunology|January 27, 2025
Nationwide multi-centric prospective study for the identification of biomarkers to predict the treatment responses of nivolumab through comprehensive analyses of pretreatment plasma exosome mRNAs from head and neck cancer patients (BIONEXT study)Kuniaki Sato, Satoshi Toh, Taku Murakami, et al.
American Journal of Ophthalmology|May 8, 2026
Genotype-phenotype correlations in RPGRIP1-associated retinal dystrophy in a nationwide Japanese cohortKei Mizobuchi, Taiga Inooka, Takuya Aoki, et al.
Journal of Medical Genetics|March 18, 2024
Disease-specific variant interpretation highlighted the genetic findings in 2325 Japanese patients with retinitis pigmentosa and allied diseasesKensuke Goto, Yoshito Koyanagi, Masato Akiyama, et al.
Ophthalmology|July 18, 2024
Genetic Risk Stratification of Primary Open-Angle Glaucoma in Japanese IndividualsMasato Akiyama, Gen Tamiya, Kohta Fujiwara, et al.
BMC Cancer|October 31, 2023
Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from JapanKenji Tsuchihashi, Mamoru Ito, Shuji Arita, et al.
JTO Clinical and Research Reports|December 4, 2023
Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA StudyYasunori Murata, Shigeru Tanzawa, Toshihiro Misumi, et al.
Pageof 22